Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,822 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,088 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05320874 | A Study of KM257 in Patients With Advanced HER2-positive or Expressing Solid Tumors. | not yet recruiting | Phase 1 | 232 | Xuanzhu Biopharmaceutical Co., Ltd.INDUSTRY | 1 | Apr 11, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Apr 11, 2022source: clinicaltrials